Effectiveness of Continuous Infusion Meropenem in Sepsis Patients: Findings from a Recent Randomized Controlled Study

2023-07-11 15:30:55

medicine

Tuesday, July 11, 2023 Milan – The administration of the beta-lactam antibiotic meropenem as a continuous infusion does not appear to have any advantage for sepsis patients treated in the intensive care unit, at least not in terms of mortality and the development of antibiotic resistance. This is shown by the results of a randomized controlled study presented by an international research group in JAMA (2023; DOI: 10.1001/jama.2023.10598)….
1689116283
#Continuous #intermittent #meropenem #not..